Table 7.
Serum ID | IFA | VN | IFA | VN | ||||
---|---|---|---|---|---|---|---|---|
(FeCoV) | (FeCoV) | (SARS-CoV-2) | (SARS-CoV-2) | |||||
#026 (21 DPC) | >1:40 | Pos | <1:4 | Neg | 1:5,120 | Pos | 1:40 | Pos |
#328 (4 DP2C) | >1:320 | Pos | <1:4 | Neg | >1:5,120 | Pos | 1:160 | Pos |
#272 (4 DP2C) | >1:320 | Pos | <1:4 | Neg | >1:5,120 | Pos | 1:80 | Pos |
#903 (4 DP2C) | >1:320 | Pos | <1:4 | Neg | >1:5,120 | Pos | 1:160 | Pos |
mAb 91C2 | <1:5 | Neg | <1:4 | Neg | 1:1,280 | Pos | 1:32 | Pos |
mAb 91G12 | <1:5 | Neg | <1:4 | Neg | 1:2,560 | Pos | 1:64 | Pos |
mAb 117C1 | <1:5 | Neg | <1:4 | Neg | 1:640 | Pos | 1:256 | Pos |
mAb 117E2 | <1:5 | Neg | <1:4 | Neg | 1:2,560 | Pos | 1:64 | Pos |
FeCoV, feline coronavirus; mAb, monoclonal antibody; DPC, days post-challenge; 4 DP2C, four days post-second challenge.